Possible andrologic markers in elevated neonatal 17-hydroxyprogesterone

Fertil Steril. 2010 Nov;94(6):2350-2. doi: 10.1016/j.fertnstert.2010.04.040. Epub 2010 May 26.

Abstract

In this prospective study, we analyzed 30 male infants with increased neonatal 17-hydroxyprogesterone (17OH-P) (patients) and for comparison 52 age-matched healthy babies (control subjects) with the aim of investigating the hypothalamic-pituitary-testis axis in the first 6 months of life. Although T, FSH, and LH levels were not significantly different in patients and control subjects, inhibin B was higher in patients than in control subjects. Therefore we suggest a clinical follow-up of these babies during childhood and puberty to verify the evolution of their condition.

Publication types

  • Evaluation Study

MeSH terms

  • 17-alpha-Hydroxyprogesterone / blood*
  • 17-alpha-Hydroxyprogesterone / metabolism
  • Adrenal Hyperplasia, Congenital / blood*
  • Adrenal Hyperplasia, Congenital / diagnosis*
  • Adrenal Hyperplasia, Congenital / metabolism
  • Andrology / methods
  • Biomarkers / analysis*
  • Biomarkers / blood
  • Case-Control Studies
  • Follow-Up Studies
  • Humans
  • Infant, Newborn / blood*
  • Male
  • Neonatal Screening / methods
  • Steroid 21-Hydroxylase / metabolism
  • Up-Regulation

Substances

  • Biomarkers
  • 17-alpha-Hydroxyprogesterone
  • Steroid 21-Hydroxylase